In memoriam: Richard Wolfenden
Richard Wolfenden, a renowned enzymologist known for his work on enzyme kinetics, died on Oct. 22, 2025. He was 90. He had been a member of the American Society for Biochemistry and Molecular Biology since 1967.
Born May 17, 1935, in Oxford, England, Wolfenden earned an A.B. degree in chemistry from Princeton University and a B.A. and M.A. in animal physiology from Exeter College, University of Oxford. He earned his Ph.D. in biochemistry from Rockefeller University. He joined the University of North Carolina at Chapel Hill in 1970, first as an associate professor of biochemistry and later as the Alumni Distinguished Professor of chemistry, biochemistry and biophysics in the UNC School of Medicine and the College of Arts and Sciences
Wolfenden was known for his extensive work on enzyme mechanisms and water affinities of biological compounds. His research also focused on the catalytic power of enzymes. In 1995, his team found that an enzyme that helps decarboxylate orotic acid, a key intermediate in pyrimidine nucleotide biosynthesis, enhances the rate of reaction by 1017-fold; without the enzyme, the reaction would take 78 million years.
His work influenced rational drug design and helped spur the development of angiotensin-converting enzyme inhibitors, or ACE inhibitors, which are widely used to treat hypertension and heart failure.
Wolfenden was elected a fellow of the American Association for the Advancement of Science, the American Academy of Arts and Sciences and the National Academy of Sciences.
To family and friends, Wolfenden was known for his gentle manner, genuine kindness and endless curiosity. To his collaborators, he was known for his clarity of purpose and lively intellect. UNC will hold a symposium to celebrate his contributions on May 18, 2026.
Wolfenden is survived by his wife, son, sister and four grandchildren.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

Tansey named department chair
He has been a faculty member at Otterbein University since 2002.

In memoriam: Joel Habener
He discovered GLP-1, which helped pave the way for transformative diabetes and obesity therapies, and he was an ASBMB member for 25 years.

In memoriam: Walter A. Shaw
He is the namesake for the Walter A. Shaw Young Investigator Award in Lipid Research and founded Avanti Polar Lipids.

Dorn named assistant professor
She will open her lab at the University of Vermont in fall 2026, and her research will focus on catalysis, synthetic methodology and medicinal chemistry.

The data that did not fit
Brent Stockwell’s perseverance and work on the small molecule erastin led to the identification of ferroptosis, a regulated form of cell death with implications for cancer, neurodegeneration and infection.

Building a career in nutrition across continents
Driven by past women in science, Kazi Sarjana Safain left Bangladesh and pursued a scientific career in the U.S.